COMMUNIQUÉS West-GlobeNewswire

VBI Vaccines Enters into License and Collaboration Agreement with Brii Biosciences for up to $129 Million plus Royalties to Develop a Functional Cure for Hepatitis B

06/12/2018 - 14:00

Upon closing, VBI received gross proceeds of $11 million, consisting of an upfront payment and an equity investment at $3.05 per share from Brii Biosciences VBI is eligible to receive an additional $117.5 million in [...]

Rexahn Pharmaceuticals Streamlines Operations and Provides Update on Pipeline

06/12/2018 - 14:00

ROCKVILLE, Md., Dec. 06, 2018 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE American: RNN), a clinical stage biopharmaceutical company developing innovative therapies to improve patient outcomes in cancers that [...]

Diamond CBD Goes Funny In New CBD Educational Awareness Ad Campaign

06/12/2018 - 14:00

"I am THC, I am CBD" video shorts use humor and nostalgia to dispel myths about hemp-derived CBD MIAMI, Dec. 06, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Diamond CBD Inc., wholly owned subsidiary of PotNetwork [...]

Uptick Newswire’s Stock Day Podcast Features Richard Van Kirk, Pro-Dex, Inc.’s CEO, to talk about the Growing Success of The Company and Plans to Keep up The Momentum

06/12/2018 - 14:00

PHOENIX, Dec. 06, 2018 (GLOBE NEWSWIRE) -- Uptick Newswire hosts Pro-Dex, Inc. (NASDAQ: PDEX) (the company) on their Stock Day Podcast. The Company specializes in the design, development, and manufacture of autoclavable [...]

NASA Deploys Medigus’ micro ScoutCam™ Miniature HD Camera During Robotic Refueling Mission

06/12/2018 - 14:00

- Advanced CMOS camera to be launched into space to help broaden satellite servicing capabilities - OMER, Israel, Dec. 06, 2018 (GLOBE NEWSWIRE) -- Medigus Ltd. (NASDAQ: MDGS) (TASE: MDGS), a medical device company [...]

Kiniksa Provides Update on U.S. FDA Review of Investigational New Drug Application for Mavrilimumab in Giant Cell Arteritis

06/12/2018 - 14:00

HAMILTON, Bermuda, Dec. 06, 2018 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) (“Kiniksa”), a biopharmaceutical company with a pipeline consisting of five product candidates across various stages of [...]

NanoVibronix Announces Publication of Study Measuring the Effect of Surface Acoustic Waves on Bacterial Load and Preventing Catheter-Associated Urinary Tract Infections

06/12/2018 - 14:00

UroShield™ reduced Colony Forming Units (CFU) count from >100,000 to 10,000 CFU or less in 25 of 29 patients in the treatment group No reported infections in the treatment group versus 27% symptomatic treated [...]

Daré Bioscience, Inc. Announces Licensing and Global Rights to Novel Phase III Product Candidate for the Treatment of Bacterial Vaginosis

06/12/2018 - 14:00

Bacterial vaginosis affects nearly 20 million women in the U.S. every year SAN DIEGO, Dec. 06, 2018 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in clinical-stage women’s health innovation, today [...]

LogicBio Therapeutics Appoints Richard Moscicki, M.D., and Michael Wyzga to Board of Directors

06/12/2018 - 14:00

CAMBRIDGE, Mass., Dec. 06, 2018 (GLOBE NEWSWIRE) -- LogicBio Therapeutics, Inc. (NASDAQ:LOGC), a genome editing company focused on developing medicines to durably treat rare diseases, today announced the appointment [...]

Arch Therapeutics Provided Corporate Update at the 11th Annual LD Micro Main Event

06/12/2018 - 13:50

Company highlighted US and EU regulatory filings and positive patent ruling in Japan FRAMINGHAM, Mass., Dec. 06, 2018 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of [...]

Brain Scientific Announces Successful Commercialization & First Purchase Order Shipment Of NeuroCap

06/12/2018 - 13:46

NEW YORK, Dec. 06, 2018 (GLOBE NEWSWIRE) -- Brain Scientific Inc. (OTC:BRSF) (“Brain Scientific” or “Company”), a medical device company combining brain analysis software with wireless sensor technologies for [...]

Auris Medical Announces Acquisition of Orphan Drug Designation and Secures Rights to In-License Additional Patents Related to Betahistine

06/12/2018 - 13:31

Acquires Orphan Drug Designation for betahistine for the treatment of obesity associated with Prader-Willi syndrome (PWS) Signs letter of intent to in-license two US patents covering use of betahistine for the treatment [...]

Pain Therapeutics Announces Initiation of a Phase II Study in Alzheimer’s Disease

06/12/2018 - 13:30

AUSTIN, Texas, Dec. 06, 2018 (GLOBE NEWSWIRE) -- Pain Therapeutics, Inc. (Nasdaq: PTIE), a biopharmaceutical company, announced today the initiation of a Phase II study to evaluate PTI-125 as a potential first line [...]

Meridian Gets FDA Clearance for New Neonatal Saliva CMV Test

06/12/2018 - 13:30

CINCINNATI, Dec. 06, 2018 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO) today announced that it has received FDA clearance for its new Alethia™ CMV Molecular Amplification Test (formerly, the illumi gene [...]

Biogen Exercises Option with Ionis to Develop and Commercialize Investigational Treatment BIIB067 for a Subtype of Familial Amyotrophic Lateral Sclerosis (ALS) Based on Positive Phase 1 Data

06/12/2018 - 13:30

Positive interim analysis demonstrated proof-of-biology and proof-of-concept for BIIB067 Biogen plans to advance BIIB067 to a pivotal clinical study Biogen paid Ionis Pharmaceuticals a $35 million one-time upfront [...]

Tetra Bio-Pharma in Process of Filing Patent Application Exceeding its Data Protection Initial Assumption for its PPP001

06/12/2018 - 12:30

Company seeks to protect shareholders’ investments ORLEANS, Ontario, Dec. 06, 2018 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc (“ Tetra ” or the “ Company ”) (TSX VENTURE: TBP) (OTCQB: TBPMF), a leader in cannabinoid-based [...]

iKang Schedules 2018 Unaudited Second Quarter Earnings Release on December 20, 2018

06/12/2018 - 11:00

BEIJING, Dec. 06, 2018 (GLOBE NEWSWIRE) -- iKang Healthcare Group, Inc. (“iKang” or the “Company”) (Nasdaq: KANG), a major provider in China’s fast growing private preventive healthcare services market, today announced [...]

FibroGen Appoints Maykin Ho, Ph.D., to Board of Directors

06/12/2018 - 10:00

SAN FRANCISCO, Dec. 06, 2018 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN), a leading biopharmaceutical company discovering and developing a pipeline of first-in-class therapeutics, today announced the appointment [...]

Rule 2.9 Announcement

06/12/2018 - 08:00

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 6 December 2018 [...]